Lineage Cell Therapeutics
LCTX
#8791
Rank
NZ$0.23 B
Marketcap
$1.04
Share price
8.98%
Change (1 day)
-42.35%
Change (1 year)

EPS for Lineage Cell Therapeutics (LCTX)

EPS in 2023 (TTM): -$0.21

According to Lineage Cell Therapeutics 's latest financial reports the company's current EPS (TTM) is -$0.23. In 2022 the company made an earnings per share (EPS) of -$0.27 an increase over its 2021 EPS that were of -$0.47.

EPS history for Lineage Cell Therapeutics from 1996 to 2023

20002005201020152020-$1$10companiesmarketcap.com

Annual EPS

Year EPS Change
2023 (TTM)-$0.21-20.63%
2022-$0.27-42.31%
2021-$0.4785.71%
2020-$0.25250%
2019-$0.07197-88.57%
2018-$0.63105.88%
2017-$0.31-153.13%
2016$0.58-154.24%
2015-$1.065.36%
2014-$1.01-30.86%
2013-$1.4688.37%
2012-$0.7719.44%
2011-$0.6533.33%
2010-$0.4968.75%
2009-$0.29-5.88%
2008-$0.31183.33%
2007-$0.11-25%
2006-$0.14-27.27%
2005-$0.20-38.89%
2004-$0.3238.46%
2003-$0.23-43.48%
2002-$0.41-26.63%
2001-$0.56-28.75%
2000-$0.79-13.73%
1999-$0.92
1997-$0.593.13%
1996-$0.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.92 1,576.92%๐Ÿ‡บ๐Ÿ‡ธ USA